Correlation Between Apogee Therapeutics, and CERo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and CERo Therapeutics Holdings,, you can compare the effects of market volatilities on Apogee Therapeutics, and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and CERo Therapeutics.

Diversification Opportunities for Apogee Therapeutics, and CERo Therapeutics

-0.5

Correlation Coefficient

Apogee Therapeutics,  CERo Therapeutics

Very good diversification

The 3 months correlation between Apogee and CERo is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and CERo Therapeutics Holdings, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and CERo Therapeutics

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 6.72 times less risky than CERo Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The CERo Therapeutics Holdings, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  8.40  in CERo Therapeutics Holdings, on September 15, 2024 and sell it today you would lose (2.73) from holding CERo Therapeutics Holdings, or give up 32.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  CERo Therapeutics Holdings,

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

CERo Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, CERo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and CERo Therapeutics

The main advantage of trading using opposite Apogee Therapeutics, and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.

The idea behind Apogee Therapeutics, Common and CERo Therapeutics Holdings, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.